Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
A SPAC II Acquisition | ASCB | Oct 31, 2024 | 11.19 | 0.00 |
A-Mark Precious Metals | AMRK | Oct 31, 2024 | 38.85 | -0.64 |
a.k.a Brands | AKA | Oct 31, 2024 | 22.99 | -3.48 |
A.O Smith | AOS | Oct 31, 2024 | 75.10 | -1.07 |
A10 Networks | ATEN | Oct 31, 2024 | 14.65 | -0.61 |
A2Z Cust2Mate Solutions | AZ | Oct 31, 2024 | 5.12 | -6.06 |
AA Mission Acquisition | AAM | Oct 31, 2024 | 10.04 | 0.00 |
AAA - A Rated Corporate Bond Ishares | QLTA | Oct 31, 2024 | 47.66 | -0.15 |
Aadi Bioscience | AADI | Oct 31, 2024 | 1.99 | +1.53 |
AAON | AAON | Oct 31, 2024 | 114.22 | -0.77 |
AAR | AIR | Oct 31, 2024 | 58.70 | -3.07 |
Abacus Life | ABL | Oct 31, 2024 | 8.64 | -0.23 |
Abbott Laboratories | ABT | Oct 31, 2024 | 113.37 | -0.94 |
AbbVie | ABBV | Oct 31, 2024 | 203.87 | +1.18 |
AbCellera Biologics | ABCL | Oct 31, 2024 | 2.73 | -1.80 |
Abeona Therapeutics | ABEO | Oct 31, 2024 | 6.41 | +0.79 |
Abercrombie & Fitch | ANF | Oct 31, 2024 | 131.79 | -3.48 |
Aberdeen Asia-Pacificome Fund | FAX | Oct 31, 2024 | 16.40 | -0.43 |
Aberdeen Australia Equity Fund | IAF | Oct 31, 2024 | 4.38 | -1.24 |
Aberdeen Emerging Markets Fund | AEF | Oct 31, 2024 | 5.39 | -0.37 |
Aberdeen Global Fund | FCO | Oct 31, 2024 | 5.84 | -0.34 |
Aberdeen Global Infrastructure | ASGI | Oct 31, 2024 | 19.60 | -1.06 |
Aberdeen Income Credit Strategies Fund | ACP | Oct 31, 2024 | 6.49 | +0.15 |
Aberdeen Income Credit Strategies Pref | ACP-A | Oct 31, 2024 | 24.14 | -1.35 |
Aberdeen Japan Equity Fund | JEQ | Oct 31, 2024 | 5.81 | -1.02 |
Abits Group | ABTS | Oct 31, 2024 | 0.54 | -2.24 |
Abivax SA - American Depositary Shares | ABVX | Oct 31, 2024 | 10.32 | -1.62 |
Able View Global | ABLV | Oct 31, 2024 | 0.92 | +2.22 |
ABM Industries | ABM | Oct 31, 2024 | 53.06 | -1.16 |
Above Food Ingredients | ABVE | Oct 31, 2024 | 0.39 | -21.31 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.